SELLAS Life Sciences (SLS) Goodwill (2011 - 2026)

SELLAS Life Sciences (SLS) reported Goodwill of $1.9 million for Q1 2026, little changed year-over-year from $1.9 million in Q1 2025, and little changed on a QoQ basis from $1.9 million in Q4 2025.

SELLAS Life Sciences (SLS) has 16 years of Goodwill data on file, last reported at $1.9 million in Q1 2026.

  • Quarterly Goodwill changed 0.0% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $1.9 million, up 0.74% from the prior year.
  • Goodwill was little changed at $1.9 million in Q1 2026 per SLS's latest filing, from $1.9 million in the prior quarter.
  • Across five years, Goodwill topped out at $1.9 million in Q1 2022 and bottomed at $1.9 million in Q4 2023.
  • The 5-year median for Goodwill is $1.9 million (2022), against an average of $1.9 million.
  • The widest annual swing landed in 2022, when Goodwill rose 0.74%; it then decreased 0.73% in 2023.
  • Tracing SLS's Goodwill over 5 years: stood at $1.9 million in 2022, then slipped by 0.73% to $1.9 million in 2023, then changed by 0.0% to $1.9 million in 2024, then rose by 0.74% to $1.9 million in 2025, then changed by 0.0% to $1.9 million in 2026.
  • Per Business Quant, the three latest SLS Goodwill figures stand at $1.9 million (Q1 2026), $1.9 million (Q4 2025), and $1.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.91 Mn
Dec 31, 2025 1.91 Mn
Sep 30, 2025 1.91 Mn
Jun 30, 2025 1.91 Mn
Mar 31, 2025 1.91 Mn
Dec 31, 2024 1.90 Mn
Sep 30, 2024 1.91 Mn
Jun 30, 2024 1.91 Mn
Mar 31, 2024 1.91 Mn
Dec 31, 2023 1.90 Mn
Sep 30, 2023 1.91 Mn
Jun 30, 2023 1.91 Mn
Mar 31, 2023 1.91 Mn
Dec 31, 2022 1.91 Mn
Sep 30, 2022 1.91 Mn
Jun 30, 2022 1.91 Mn
Mar 31, 2022 1.91 Mn
Dec 31, 2021 1.90 Mn
Sep 30, 2021 1.91 Mn
Jun 30, 2021 1.91 Mn
Mar 31, 2021 1.91 Mn
Dec 31, 2020 1.91 Mn
Sep 30, 2020 1.91 Mn
Jun 30, 2020 1.91 Mn
Mar 31, 2020 1.91 Mn
Dec 31, 2019 1.91 Mn
Sep 30, 2019 1.91 Mn
Jun 30, 2019 1.91 Mn
Mar 31, 2019 1.91 Mn
Dec 31, 2018 1.90 Mn
Sep 30, 2018 1.91 Mn
Jun 30, 2018 1.91 Mn
Mar 31, 2018 1.91 Mn
Dec 31, 2017 1.90 Mn
Sep 30, 2017 5.39 Mn
Jun 30, 2017 5.90 Mn
Mar 31, 2017 5.90 Mn
Dec 31, 2016 5.90 Mn
Sep 30, 2016 5.90 Mn
Jun 30, 2016 5.90 Mn
Mar 31, 2016 5.90 Mn
Dec 31, 2015 5.90 Mn
Sep 30, 2015 5.90 Mn
Jun 30, 2015 6.07 Mn
Mar 31, 2015 6.07 Mn
Dec 31, 2014 5.90 Mn
Sep 30, 2014 5.90 Mn
Jun 30, 2014 5.90 Mn
Mar 31, 2014 5.90 Mn
Dec 31, 2013 5.90 Mn
Sep 30, 2013 5.90 Mn
Jun 30, 2013 5.90 Mn
Mar 31, 2013 5.90 Mn
Dec 31, 2012 5.90 Mn
Sep 30, 2012 5.90 Mn
Mar 31, 2012 5.90 Mn
Dec 31, 2011 5.90 Mn
Sep 30, 2011 845,000.00
Jun 30, 2011 845,000.00